1. Home
  2. DCTH vs GCO Comparison

DCTH vs GCO Comparison

Compare DCTH & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.61

Market Cap

372.5M

Sector

Health Care

ML Signal

HOLD

Logo Genesco Inc.

GCO

Genesco Inc.

HOLD

Current Price

$38.33

Market Cap

432.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCTH
GCO
Founded
1988
1924
Country
United States
United States
Employees
156
N/A
Industry
Medical/Dental Instruments
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
372.5M
432.0M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
DCTH
GCO
Price
$10.61
$38.33
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$22.00
$33.00
AVG Volume (30 Days)
477.0K
174.4K
Earning Date
05-07-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
107.53
171.84
EPS
N/A
1.25
Revenue
N/A
$2,606,898,000.00
Revenue This Year
$24.54
$0.78
Revenue Next Year
$33.15
$2.12
P/E Ratio
N/A
$31.93
Revenue Growth
N/A
13.71
52 Week Low
$8.12
$19.62
52 Week High
$16.68
$40.39

Technical Indicators

Market Signals
Indicator
DCTH
GCO
Relative Strength Index (RSI) 46.90 59.81
Support Level $10.55 $30.79
Resistance Level $11.14 N/A
Average True Range (ATR) 0.49 2.12
MACD -0.09 0.34
Stochastic Oscillator 28.19 77.00

Price Performance

Historical Comparison
DCTH
GCO

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About GCO Genesco Inc.

Genesco Inc sells footwear, headwear, sports apparel, and accessories. It has four reportable business segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass. The brands of the company are: Journeys; Journeys Kidz; Little Burgundy; Schuh; Johnston & Murphy; and Genesco Brands Group.

Share on Social Networks: